She has more than fifteen years of experience leading interdisciplinary efforts in drug discovery, epigenetics, immunology, and cancer research. Her work has been instrumental in understanding protein structure/function relationships, characterizing drug-target interactions, and elucidating their downstream effects in health and disease. She contributes her expertise to multiple high-profile research consortia funded by NIH and HHMI. She is currently a Vice-Chair of the International Society of HDX-MS. As a recognized expert in her field, Malvina has been frequently invited as a selected speaker at scientific conferences and has co-organized international symposia focused on structural proteomics. Prior to joining the Broad Institute in 2016, Malvina gained experience in MS-based proteomics and protein structure/function by HDX-MS. She undertook postdoctoral research at the Center for Drug Discovery at Northeastern University to develop MS-based approaches to characterize cannabinoid receptor-ligand interactions. She subsequently worked as a research scientist at the Institute of Molecular Biology and Biotechnology of the Foundation for Research and Technology – Hellas (FORTH), Heraklion, Greece, working on MS-based membrane proteomics. During this term, she also served as an EMBO visiting fellow at the University of Southern Denmark to study the structure of proteins involved in bacterial protein translocation by HDX-MS. She subsequently undertook a postdoctoral fellowship at the Perelman School of Medicine (UPenn) investigating protein structure and protein-ligand interactions of components of the human complement system. Malvina obtained a M.S. and Ph.D. in chemistry at Manchester Metropolitan University, as well as a B.Sc. in environmental sciences from the University of the Aegean.